Back to home
DEALS & FUNDINGApril 7, 2026·5 min read
Gilead Acquires Tubulis for Up to $5B, Building a Munich ADC Hub
Gilead enters a definitive agreement to acquire German biotech Tubulis for $3.15B upfront plus $1.85B in milestones. The deal adds best-in-class ADC linker-payload technology and creates a dedicated Munich R&D hub as the ADC sector surpasses $20B.
The full analysis is published in the weekly biotech.today newsletter — subscribe for free to get the next issue in your inbox.